This announcement is a separate document:
中國抗體-B：(1) 關連交易 - 建議發行100,000,000港元於二零二二年到期的可換股債券可能根據特別授權發行股份及(2) 股東特別大會通告
SINOMAB BIO-B: (1) CONNECTED TRANSACTION -PROPOSED ISSUE OF HK$100,000,000 CONVERTIBLE BONDSDUE 2022POSSIBLE ISSUE OF SHARES UNDER SPECIFIC MANDATEAND(2) NOTICE OF EGM
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.